Burning Rock’s Multi-Cancer Detection Blood Test Gets FDA Breakthrough Device Designation
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Cancer, Diagnostic Technologies |
Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.
Read MorePosted by Andy Lundin | Jan 2, 2023 | Colorectal |
Guardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.
Read MorePosted by Andy Lundin | Nov 29, 2022 | Cancer |
As cancers grow and potentially spread to new parts of the body, they often shed cells and DNA into the blood stream.
Read MorePosted by Chris Wolski | Nov 22, 2022 | Unknown Origin & Other Cancer Types |
Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics’ liquid biopsy platform in a new tumor type.
Read MorePosted by Andy Lundin | Nov 18, 2022 | Unknown Origin & Other Cancer Types |
A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.
Read More